Biomarkers for high-risk influenza patients: what are the next steps?

Expert Rev Mol Diagn. 2018 Mar;18(3):205-206. doi: 10.1080/14737159.2018.1420475. Epub 2017 Dec 26.

Authors

Benjamin M Tang^{1

2

3}, Maryam Shojaei^{1

2}, James Branley⁴, Anthony McLean¹

Affiliations

¹ a Department of intensive care medicine , Nepean Hospital , Sydney , Australia.
² b Centre for immunology and allergy research , the Westmead institute for medical research , Sydney , Australia.
³ c Respiratory virus infection research , Marie Bashir institute for infectious diseases and biosecurity , Sydney , Australia.
⁴ d Department of microbiology , Nepean Hospital , Sydney , Australia.

PMID: 29264948
DOI: 10.1080/14737159.2018.1420475

No abstract available

Keywords: Influenza; biomarkers; host response; risk stratification.

Publication types

Editorial

MeSH terms

Biomarkers / blood
Disease Susceptibility / blood
Disease Susceptibility / epidemiology
Humans
Influenza, Human / blood*
Influenza, Human / epidemiology
Pandemics*

Substances

Biomarkers